甲状腺老化通过TH/TRα/PINK1诱导骨骼肌自稳态失衡致肌少症机制研究
批准号:
82071582
项目类别:
面上项目
资助金额:
56.0 万元
负责人:
段宇
依托单位:
学科分类:
衰老相关疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
段宇
中文摘要
肌少症与甲状腺老化密切关联。已知骨骼肌是甲状腺激素(TH)最大靶器官,TH对其调节依赖于甲状腺信号三联征(TRIAD)。我们借助衰老模型研究发现,甲状腺激素受体α(TRα)是TRIAD增龄性改变核心因子;伴随衰老基因p16,p21,p53表达升高,骨骼肌量下降,MyHC亚型发生变化,线粒体自噬相关基因PINK1受抑;通过基因芯片与生物信息技术发现具有甲状腺激素反应元件的miR-183-5p随增龄升高,靶基因是自噬相关基因PINK1。据上我们假设:TRα是TRIAD老化关键因子,TRα与TH在骨骼肌细胞核内结合,锚定激活miR-183-5p,后者通过调控PINK1基因,引起线粒体自噬损伤,肌细胞修复障碍。课题拟通过体内/体外模型、基因芯片与数据分析、Pull-down分析等,研究并阐述甲状腺老化通过TH/TRα/PINK1诱导骨骼肌自稳态失衡致肌少症的发生机制,为寻找肌少症治疗靶点提供思路。
英文摘要
The mechanism of sarcopenia is still unclear though senescent thyroid with age showed intimate relationship with it. It had been demonstrated that skeletal muscle was the most important target of thyroid hormone (TH), and TH could regulate it through thyroid signaling pathway, while the signaling triad (TRIAD), i.e transmembrane transporter, intracellular deiodination and TR-mediated gene transcription, constitute the basis for cellular customization of this signaling. In our primary experiment with skeletal muscle of geriatric mouse, it was found thyroid receptor α (TRα) was the prominent points of aged TRIAD, which showed suppressive expression of its gene and protein and intensive dysfunction. Previously, we also found, accompanying with increased expression of geriatric genes, such as p16, p21 and p53, the muscle mass, strength and muscle function were all reduced, and the ratio of subtypes of myosin heavy chain(MyHC) displayed typically senescent phenomena, and PINK1, a distinct gene of mitochondrial autophagy, was showed decreased. With the technique of gene chip and bioinformatic analysis technique, we found miR-183-5p, consistantly increased with age, and TH could act it through its specific TH/TRα promoter. Furthermore, it would be the regulator of PINK1 with the prediction of bioinformation. To date, we hypothesis that TRα acts the pivotal role in geriatric TRIAD, and senescent TRα , combining with TH, could promote and activate miR-183-5p in the nuclear of skeletal muscle cells, while the activated miR-183-5p exporting from nuclear, suppresses the gene of PINK1 and induces abnormality of mitophagy which destroys homeostasis of skeletal muscle and induces sarcopenia. In this project, we would utilize a series of molecular biological techniques such as Western-blot, immunofluorescence, siRNA, chromatin immunoprecipitation assay, microarray analysis and RNA pull-down assay to discuss the mechanism of sarcopenia induced by senescent thyroid through TH/TRα/PINK1 pathway, thus we hope to provide a novel approach in preventing sarcopenia from the new perspective of thyroid.
肌少症与甲状腺老化密切关联。已知骨骼肌是甲状腺激素(TH)最大靶器官,TH对其调节依赖于甲状腺信号三联征(TRIAD)。课题组前期研究发现,甲状腺激素受体α(TRα)是TRIAD增龄性改变核心因子,且TRα能够参与PINK1介导的线粒体自噬,但其潜在机制不明。本课题开展以下研究:1.明确TRIAD路径中的关键因素及线粒体在骨骼肌中随增龄发生的精细变化;2.探讨TRα通过miR-183-5p调控PINK1介导骨骼肌细胞线粒体自噬的可能机制;3.明确TRα通过PINK1调控骨骼肌线粒体自噬的具体机制。课题组以自然衰老小鼠以及小鼠成肌细胞系为研究对象,采用PCR、Western-blot、免疫荧光染色、ChIP-seq、RNA-seq等技术,探讨TRα调控PINK1/Parkin介导骨骼肌线粒自噬的具体机制。我们研究发现:1.骨骼肌衰老过程中出现以线粒体自噬减弱为主要表现的线粒体功能紊乱,同时TRIAD核心受体TRα随龄表达下调,并与骨骼肌质量与功能变化显著正相关;2.TRα正向调控PINK1/Parkin介导的线粒体自噬水平,并影响骨骼肌细胞线粒体氧化呼吸、ROS以及线粒体动力学;3.TRα负向影响miR-183-5p表达,而miR-183-5p能够负向调控PINK1/Parkin介导的线粒体自噬水平,但TRα与miR-183-5p以及miR-183-5p与PINK1之间并无直接靶向证据,这表明TRα与PINK1之间存在另外的调控机制;4.ChIP-seq及RNA-seq分析发现RNA结合蛋白CLUH作为TRα潜在靶基因,能够结合PINK1mRNA以调控其转运翻译,这表明CLUH或是参与TRα与PINK1之间隐秘调控的关键角色;5.ChIP-qPCR及双荧光素酶报告基因技术均证实TRα能够结合CLUH启动子区域并正向调控CLUH转录,同时细胞实验证实CLUH能够正向调控PINK1/Parkin介导的线粒体自噬水平。课题研究表明:TRα可以通过PINK1/Parkin通路激活骨骼肌细胞线粒体自噬,但并非靶向miR-183-5p以调控PINK1表达,而是转录调控RNA结合蛋白CLUH以稳定PINK1mRNA的转运及翻译过程。骨骼肌衰老过程中,TRα的表达下调抑制CLUH转录,损害PINK1/Parkin介导的线粒体自噬,进而导致骨骼肌细胞线粒体稳态失衡,加剧肌少症的发生。
LncRNA-NONRATT014386调控Tubb3基因在多氯联苯致甲状腺细胞自噬损伤中的机制研究
-
批准号:81670724
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:段宇
-
依托单位:
环境内分泌干扰物多氯联苯118通过AKT/FoxO3a/NIS诱导甲状腺细胞功能障碍的研究
-
批准号:81170726
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:段宇
-
依托单位:
国内基金
海外基金